MRNA | Moderna Therapeutics

The Big Pharma Giants Are Down
It's evident that big pharma giant Moderna (NASDAQ: MRNA) is going through troubled times. Worse, it's dragging other big Pharma giants with it.
By Precious Njoku | 1 month ago

Why Pfizer and Moderna Would Profit As CDC Recommends Covid Vaccine For Toddlers
Why Many parents are concerned about the effect of the coronavirus pandemic on their children.
By Precious Njoku | 5 months ago

2 Top Biotech Stocks With Huge Potential
Below stocks have been added to my watchlist.
By Precious Njoku | 8 months ago

Moderna up nearly 15% on strong quarterly results: here’s what you should now
Moderna reported its financial results for the fourth quarter on Thursday. Shares are up nearly 15%.
By Khan | 9 months ago

Worst Performing S&P 500 Stocks You Should Dump Immediately
If you are still in profit, dump Moderna stock now and wait for re-entry at a much lower zone.
By Precious Njoku | 10 months ago

Why Pfizer stock is making higher highs
Compared to its peers like Johnson and Johnson, and Merck, who are also vaccine manufacturers, Pfizer is a better bet and gives higher expected returns.
By Precious Njoku | 11 months ago

Is the Moderna vaccine effective against the Omicron Variant?
Speaking on mRNA-1273 and its effectiveness in trials against Omicron, Dr Paul Burton said: “It’s highly effective, and it’s extremely safe.
By Precious Njoku | 11 months ago

Better Investment: Pfizer or Moderna
This week I take a look at two stalwarts in the pharmaceutical industry, and the effect they have had on investors in the race for a COVID-19 vaccine.
By Mike Sakuraba | 1 year ago

AstraZeneca confuses investors after reporting two different efficacy rates achieved by its Covid-19 vaccine
AstraZeneca will sell its vaccine to governments at significantly lower prices as compared to Pfizer and Moderna.
By Staff | 2 years ago

Moderna Inc. (MRNA) says its Covid-19 vaccine more than 94 percent effective in Phase-III trials
Pfizer shares fell nearly 3 percent in the pre-market trading Monday following Moderna’s announcement.
By Staff | 2 years ago